Grants, awards and scholarships proudly funded by ERF allow the SNMMI to keep its commitment to supporting the next generation of researchers and advancing molecular imaging and therapy. This support of early career pilot grants fills a funding void for young innovators who need funding to demonstrate the feasibility of their novel ideas before they can apply for larger government grants from the National Institutes of Health, National Science Foundation or other sources.
The 2018 ERF/NETRF $50,000 Nuclear Medicine Pilot Research Grant in NETS is sponsored by the Neuroendocrine Tumor Research Foundation with the generous support of the Margie and Robert E. Petersen Foundation.
A six-month, mid-term, written progress report will be required, outlining all progress to date. At the conclusion of the award period, the recipient must provide ERF with a final written report of the project performed during the award period and budget reconciliation. Additionally, a brief annual update for the five years following the research will be required including:
1. Investigator’s future clinical and research plans, especially regarding the field of neuroendocrine tumors and molecular imaging;
2. Listing of reference citations for all articles or presentations arising from the recipient’s research project;
3. Listing of all subsequent funding that has been secured for the research project from other agencies and entities.
1. Basic or clinical scientists with an advanced degree, such as MD, PhD, or equivalent, are eligible.
2.The research may be done in any country.
3. Awardee must hold a full-time faculty or equivalent position in an educational institution when the award starts.
4. Applicant must be no more than five years post training (most recent training; training includes residency, MD/PhD training, professional school, graduate school, post doc, or fellowship).
5. Applicant must not have served as the principal investigator of a peer-reviewed grant for more than $50,000 in a single calendar year.
6. Preference will be given to individuals who have demonstrated great potential for a research career in the field of nuclear medicine/molecular imaging and whose research focuses on translational in vivo studies that include radionuclide imaging or therapy for NETS.
To Apply/Submission Requirements
There is no application form to complete. All packaged applications must have the following components in the order listed. Incomplete applications will not be considered.
1. Title page: Applicant Name, Project Title, Institution
2. Principal Investigator’s Current Curriculum Vitae
3. Research Plan (no more than 3 pages) containing the following elements:
- Specific Aims
- Background and Significance
- Preliminary Data (if available)
4. Personal Statement by the Candidate (1-2 pages): the applicant should include description of any past research projects, evidence of interest in neuroendocrine tumors*, and description of how the project will contribute to the future development of the candidate as a clinician and/or investigator in the field of neuroendocrine tumors.
*Neuroendocrine tumors can occur throughout the body, but primary sites include the gastrointestinal tract, pancreas, rectum, lungs, and appendix. The majority of neuroendocrine tumors can be divided into two classes: carcinoid and pancreatic neuroendocrine tumors. Pheochromocytoma is a rare form of neuroendocrine tumor.
5. NIH Biosketch of the Applicant (2-page maximum)
6. Letter of Institutional Support (1 page)
7. Proposed Budget: The $50,000 grant can be used to support the salary of the applicant, research costs and/or travel. NETRF grantees are expected to attend its annual research symposium annually in the spring to report on progress. Travel to and from that event in Boston is permissible in the grant’s travel budget.
Please note: No grantee may receive more than one research grant from ERF in any one year. Likewise, no other grant request will be considered until a satisfactory summary of an earlier grant is received.
Evaluation and Selection Criteria
1. The proposal is highly relevant to advancing molecular imaging.
2. The work is completely original and innovative.
3. The proposal reflects sound methodology that is likely to prove the hypothesis.
4. The protocol is based on good, scientific reasoning.
5. The applicant has the knowledge/skills, resources to successfully conclude this project.
6. The applicant has the support of his/her institution.
There is no formal application form. Applicants should provide every item listed under the “Submission Requirements” in the order listed. Only complete packages should be submitted via email by 5:00 p.m. EDT U.S. on September 29, 2017. Incomplete packages will not be considered and ERF is not responsible for ensuring packages are complete.
Electronically submit cover letter with all
documentation listed under “submission requirements” to: firstname.lastname@example.org
Email subject: ‘NETS Pilot Research Grant Material Submission – LAST NAME’
Funding of this award is subject to the approval and availability of grant funds appropriated to ERF. Therefore, ERF reserves the right to alter the number of investigator awards, terms and allowances.